Literature DB >> 21247606

Imaging strategy for infants with urinary tract infection: a new algorithm.

Iulian Preda1, Ulf Jodal, Rune Sixt, Eira Stokland, Sverker Hansson.   

Abstract

PURPOSE: We analyzed clinical data for prediction of permanent renal damage in infants with first time urinary tract infection.
MATERIALS AND METHODS: This population based, prospective, 3-year study included 161 male and 129 female consecutive infants with first time urinary tract infection. Ultrasonography and dimercapto-succinic acid scintigraphy were performed as acute investigations and voiding cystourethrography within 2 months. Late scintigraphy was performed after 1 year in infants with abnormality on the first dimercapto-succinic acid scan or recurrent febrile urinary tract infections. End point was renal damage on the late scan.
RESULTS: A total of 270 patients had end point data available, of whom 70 had renal damage and 200 did not. Final kidney status was associated with C-reactive protein, serum creatinine, temperature, leukocyturia, non-Escherichia coli bacteria, anteroposterior diameter on ultrasound and recurrent febrile urinary tract infections. In stepwise multiple regression analysis C-reactive protein, creatinine, leukocyturia, anteroposterior diameter and non-E.coli bacteria were independent predictors of permanent renal damage. C-reactive protein 70 mg/l or greater combined with anteroposterior diameter 10 mm or greater had sensitivity of 87% and specificity of 59% for renal damage. An algorithm for imaging of infants with first time urinary tract infection based on these results would have eliminated 126 acute dimercapto-succinic acid scans compared to our study protocol, while missing 9 patients with permanent renal damage.
CONCLUSIONS: C-reactive protein can be used as a predictor of permanent renal damage in infants with urinary tract infection and together with anteroposterior diameter serves as a basis for an imaging algorithm.
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21247606     DOI: 10.1016/j.juro.2010.10.043

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Screening high-grade vesicoureteral reflux in young infants with a febrile urinary tract infection.

Authors:  Jeng-Daw Tsai; Chang-Ting Huang; Pei-Yi Lin; Jui-Hsing Chang; Ming-Dar Lee; Fu-Yuan Huang; Bing-Fu Shih; Han-Yang Hung; Chyong-Hsin Hsu; Hsin-An Kao; Chun-Chen Lin
Journal:  Pediatr Nephrol       Date:  2012-03-01       Impact factor: 3.714

Review 2.  Long-term, low-dose prophylaxis against urinary tract infections in young children.

Authors:  Per Brandström; Sverker Hansson
Journal:  Pediatr Nephrol       Date:  2014-06-07       Impact factor: 3.714

Review 3.  Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children.

Authors:  Nader Shaikh; Jessica L Borrell; Josh Evron; Mariska M G Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2015-01-20

4.  Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children.

Authors:  Kai J Shaikh; Victor A Osio; Mariska Mg Leeflang; Nader Shaikh
Journal:  Cochrane Database Syst Rev       Date:  2020-09-10

5.  Different imaging strategies in febrile urinary tract infection in childhood. What, when, why?

Authors:  Diego De Palma; Gianantonio Manzoni
Journal:  Pediatr Radiol       Date:  2013-03-24

6.  A novel approach to evaluating the benefit of post-urinary tract infection renal ultrasonography, using decision curve analysis.

Authors:  Luke Harper; Xavier Delforge; Sophie Maurin; Valerie Leroy; Jean-Luc Michel; Frederique Sauvat; Cyril Ferdynus
Journal:  Pediatr Nephrol       Date:  2016-05-14       Impact factor: 3.714

Review 7.  Dimercaptosuccinic acid scan or ultrasound in screening for vesicoureteral reflux among children with urinary tract infections.

Authors:  Nader Shaikh; Russell B Spingarn; Stephanie W Hum
Journal:  Cochrane Database Syst Rev       Date:  2016-07-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.